When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Thiazolidinedione - Wikipedia

   en.wikipedia.org/wiki/Thiazolidinedione

   A 2020 Cochrane systematic review did not find enough evidence of reduction of all-cause mortality, serious adverse events, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to Thiazolidinedione for treatment of type 2 diabetes. [26]

3. Phenylpropanolamine - Wikipedia

   en.wikipedia.org/wiki/Phenylpropanolamine

   Phenylpropanolamine was first synthesized in the early 20th century, in or around 1910. [21] [11] It was patented as a mydriatic in 1913. [21] The pressor effects of phenylpropanolamine were characterized in the late 1920s and the 1930s. [21] Phenylpropanolamine was first introduced for medical use by the 1930s. [23] [11]

4. Propranolol - Wikipedia

   en.wikipedia.org/wiki/Propranolol

   Diabetes mellitus or hyperthyroidism, since signs and symptoms of hypoglycemia may be masked; Peripheral artery disease and Raynaud syndrome, which may be exacerbated; Phaeochromocytoma, as hypertension may be aggravated without prior alpha blocker therapy; Myasthenia gravis, which may be worsened; Other drugs with bradycardic effects

5. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]

6. Ozempic’s health benefits keep growing, but are the risks ...

   www.aol.com/ozempic-health-benefits-keep-growing...

   Novo Nordisk is the maker of Ozempic, which is approved for type 2 diabetes treatment and reduced risk of cardiovascular events. The risk of gastrointestinal problems — including nausea, ...

7. Canagliflozin - Wikipedia

   en.wikipedia.org/wiki/Canagliflozin

   Canagliflozin is indicated to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes; to reduce the risk of major heart-related events such as heart attack, stroke, or death in people with type 2 diabetes who have known heart disease; and to reduce the risk of end-stage kidney disease, worsening of kidney function, heart-related death, and being hospitalized for ...